Home › Myelofibrosis › Minnesota › Minneapolis
Myelofibrosis clinical trials in Minneapolis, MN
4 studies for Myelofibrosis are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RecruitingPhase 1/2
- University of Minnesota, Minneapolis
Allo HSCT Using RIC and PTCy for Hematological Diseases
RecruitingPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
RecruitingPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
RecruitingObservational study
- Center for International Blood and Marrow Transplant Research, Minneapolis
Myelofibrosis trials in other cities
- Houston, TX19 studies
- New York City, NY18 studies
- Boston, MA12 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- Columbus, OH11 studies
- Miami, FL10 studies
- Nashville, TN9 studies
- Cleveland, OH9 studies
- Baldwin Park, CA9 studies
- Tampa, FL9 studies
- Atlanta, GA9 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer23 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer19 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.